GOSS Next Earnings Date Notes

— Gossamer Bio (ticker: GOSS) is a clinical-stage biopharmaceutical company focused on discovering, developing, & commercializing novel therapeutics in the areas of immunology, inflammation, & oncology, with a particular emphasis on pulmonary arterial hypertension (PAH). The company's lead asset, seralutinib, is in Phase 3 trials for PAH & represents the core of its pipeline. For investors tracking Gossamer's progress, the most relevant business metrics are clinical trial milestones, data readouts, regulatory update timelines, & the pace of enrollment in key studies—all of which directly impact long-term potential. Additionally, cash runway & operating expenses are critical, since Gossamer, like many biotechs, will rely on external funding until commercial revenues begin. Listening to the upcoming earnings call will offer valuable insight into trial progress for seralutinib, updates on other pipeline programs, partnerships, & management's commentary on cash position & guidance for future quarters. Progress against these key metrics will best illuminate the company’s execution, risk profile, & eventual chances of commercial success. The next projected earnings date for GOSS is 3/27/2026 after close (stay tuned for a confirmed earnings date once announced).

GOSS Next Earnings Date FAQ

On this page we presented the GOSS Next Earnings Date information for Gossamer Bio along with recent past earnings dates. For Q3 of 2025, GOSS reported earnings of -0.210/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, GOSS reported earnings of -0.170/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, GOSS reported earnings of -0.160/share, with the earnings report taking place on 5/15/2025. For Q4 of 2024, GOSS reported earnings of -0.150/share, with the earnings report taking place on 3/13/2025. For Q3 of 2024, GOSS reported earnings of -0.140/share, with the earnings report taking place on 11/7/2024. Based on these past earnings dates, the projected next earnings date for GOSS is 3/27/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Gossamer Bio. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Gossamer Bio shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Gossamer Bio next earnings dates as well as any other stock out there in our coverage universe, to see when the next GOSS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up GOSS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the GOSS next earnings date.